详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

A Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

单位： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Resp, Shanghai, Peoples R China [3]Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China [4]Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China [5]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Oncol, Wuhan, Hubei, Peoples R China [6]Zai Lab Shanghai Co Ltd, Shanghai, Peoples R China

出处：

DOI：

ISSN：

关键词： niraparib small cell lung cancer

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区医学

小类 | 2 区肿瘤学 2 区呼吸系统

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2016]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

最新[2024]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 20.8 最新[2024版] 18.4 最新五年平均 6.595 出版当年[2016版] 5.983 出版当年五年平均 5.04 出版前一年[2015版] 10.34 出版后一年[2017版]

第一作者：

第一作者单位： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]A Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients [2]Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC) [3]Updates of the NCCN guidelines for small cell lung cancer [4]Immunotherapy in advanced non-small-cell lung cancer withEGFRmutations [5]Comparison of clinical characteristics and prognoses of patients with T1 non-small cell lung cancer and small cell lung cancer in a Chinese real-world study [6]Small Cell Versus Non-Small Cell Lung Cancer: Survival Difference in 1428 Patients From a Single-Institution [7]Progress of non-small-cell lung cancer with ROS1 rearrangement [8]MiR-130a Overcomes Gefitinib Resistance by Targeting Met in Non-Small Cell Lung Cancer Cell Lines [9]Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer [10]Comparison of clinical characteristics and prognoses of patients with T1 non-small cell lung cancer and small cell lung cancer in a Chinese real-world study